NCT03977415View on ClinicalTrials.gov

Interstitial Lung Disease in Early Rheumatoid Arthritis

UnknownOBSERVATIONAL
Enrollment

76

Participants

Timeline

Start Date

March 27, 2018

Primary Completion Date

February 1, 2020

Study Completion Date

August 1, 2021

Conditions
Rheumatoid ArthritisInterstitial Lung Disease
Trial Locations (1)

80206

RECRUITING

National Jewish Health, Denver

Sponsors

Collaborators (1)

Boehringer Ingelheim
All Listed Sponsors
collaborator

Boehringer Ingelheim

INDUSTRY

lead

National Jewish Health

OTHER

NCT03977415 - Interstitial Lung Disease in Early Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter